Technology Transfer and Market Access for Biologics and Medical Aesthetics

Atlas integrates scientific development, regulatory execution, and partner-enabled manufacturing to accelerate compliant product launches across the Middle East and beyond.

Request a Technology Transfer Call Share Your Project Brief
Overview

What Atlas Delivers

Atlas supports partners and product owners with an end-to-end technology-transfer pathway - from feasibility and gap assessment to documentation packages, manufacturing onboarding, and commercialization enablement.

Complete Value-Creation Platform

Atlas Pharma is engineered as a complete value-creation and brand-development platform: we connect transfer-ready science and manufacturing onboarding with regulatory readiness, market access, and in-market execution - ensuring that registration and marketing investments translate into sustainable commercial outcomes.

  • Technology transfer program management and cross-functional governance
  • CMC-aligned documentation and technical data-room structuring
  • Analytical and process method transfer coordination
  • Cold chain and controlled-temperature distribution readiness
  • Market access and regulatory coordination
  • Execution-ready marketing and go-to-market planning
  • Clinical study execution support and evidence-generation coordination
Explore Technology Transfer Framework
Atlas Group
Framework

Technology Transfer Process

Structured stepwise framework that converts development outputs into controlled, auditable, and production-ready packages.

1) Scope and Feasibility

Define product scope, target markets, timelines, and the minimum data package required for transfer and registration.

2) Gap Assessment

Assess raw materials, process train, analytical methods, equipment fit, and quality requirements.

3) Transfer Package Build

Structure the technical dossier: specifications, methods, batch documentation, stability plan, and change-control principles.

4) Site Onboarding and Readiness

Align roles, training, materials procurement, and production planning including cold chain where applicable.

5) Engineering and Scale-up Coordination

Coordinate engineering runs, method bridging, and process optimization within approved boundaries.

6) Validation and Lifecycle Support

Support validation planning, documentation completion, and ongoing improvements under change control.

Request Transfer Readiness Outline
Technology Transfer Framework
Focus

Medical & Metabolic Platforms

Transfer-ready technology frameworks that can be deployed with qualified partners under controlled programs.

Medical Aesthetics Platforms

PLA/CMC microsphere system designed for volumization and dermal remodeling with lyophilized manufacturing.

Poly(D,L-lactide) microspheres suspended in biocompatible carrier (CMC gel), designed to support volumization and dermal remodeling over 12–24 months.

Large-volume, cross-linked HA for soft-tissue contouring; pharmaceutical-grade, controlled manufacturing.

Prefilled syringes, multiple gel grades, rheology differentiation for tailored tissue integration.

Skin & scalp solutions with polynucleotides, HA, peptides, vitamins, antioxidants, and metabolic cofactors like NAD+.

Combines recombinant collagen with polynucleotides and HA for skin hydration, texture, and brightening.

TCA + multi-acid exfoliation system (AHA/BHA/PHA) with supportive amino acids, vitamins, and emollients.

Lyophilized exosome-centric formulation for skin & scalp, with high-purity, dedicated diluents, and quality control.

Botulinum toxin type A sterile injectables and hyaluronic acid-based injectable platforms, crosslinking and rheology tuning for multiple product grades.

Metabolic & Biologics Platforms

Recombinant, sterile injectable platform with full CMC and analytical/QC transfer support.

Synthetic peptide platform for long-acting injectable development with full transfer & manufacturing support.

Sterile injectable platform with peptide process assets, drug-product transfer package, and QC methods.

Combines incretin and glucagon receptor activity for next-gen metabolic programs; full transfer and quality documentation included.

Oral small-molecule platform targeting GLP-1 receptor; technology-transfer ready for manufacturing & development.
Focus

Core Technology Platforms

Transfer-ready technology frameworks that can be deployed with qualified partners under controlled programs.

Biologics & Advanced Therapeutics

Sterile & Analytical Platforms

Aseptic processing, freeze-drying, formulation development, and QC onboarding packages for injectable products.

Medical Aesthetics

Botulinum toxin, hyaluronic acid platforms, fillers, and mesotherapy solutions with multi-market regulatory pathways.

Metabolic & Anti-Obesity

GLP-1 agonists, dual incretin peptides, and oral non-peptide platforms with transfer-ready documentation.

Biologics

Anti-TNFα monoclonal antibodies and other complex biologics with comprehensive CMC transfer packages.

Medical Aesthetics
Regulatory & Market Access

Pathway planning, dossier structuring, and region-specific registration coordination for MENA and EU entry support.

Partnership Models
Supply Chain & Cold Chain

Procurement planning, controlled-temperature distribution readiness, and market deployment support with serialization readiness.

Market Expansion
Clinical Operations

Feasibility, CRO/site coordination, GCP-aligned study execution, and evidence packaging for submission dossiers.

Services

Core Capabilities

Marketing, market access, clinical operations, and comprehensive support across modalities.

Marketing & Commercial Execution

  • Market landscaping and opportunity sizing
  • Channel architecture and partner model design
  • Pricing and tender readiness strategy
  • KOL strategy and scientific engagement
  • Launch playbooks and promotional governance

Regulatory & Quality Systems

  • Document control and version governance
  • Risk-based planning for critical steps
  • Partner qualification and role definition
  • Change control and lifecycle management
  • Multi-market regulatory strategy

Clinical & Evidence Generation

  • Clinical feasibility and study strategy
  • CRO/site selection and vendor oversight
  • Clinical supply planning and logistics
  • GCP-aligned operational quality controls
  • Evidence packaging for submission dossiers
Quality

Quality by Design, Executed Through Control

Atlas embeds quality expectations into every transfer program through controlled documentation, traceability, and partner qualification.

01

Document Control and Version Governance

All transfer activities are managed under documented governance with version control across all technical packages and supporting documentation.

02

Risk-Based Planning for Critical Materials and Methods

Structured risk assessment identifies critical parameters, process steps, and control strategies aligned with intended product performance.

03

Partner Qualification and Role Definition

Clear definition of responsibilities, capability assessment, and pre-execution qualification before any transfer activity begins.

04

Change Control Mindset from Day One

Every modification to process, methods, or materials is evaluated, documented, and approved before implementation to maintain compliance.

05

Confidentiality and IP Protection

Comprehensive IP protection framework with controlled data access, confidentiality agreements, and alignment with project scope requirements.

Footprint

Global Operating Model

Built to connect regions, partners, and pathways - enabling efficient execution from concept to market.

Global Presence Map
Iran
UAE
Turkey
Iraq
China
Korea
Spain

🇮🇷 Iran - Regional Operations (R&D & Distribution)

Scientific Base and Market Access

Established partnerships and ongoing commercial activities supporting biologics and medical aesthetics initiatives across the Middle East region.

🇦🇪 UAE - Regional Operations (R&D & Distribution)

Scientific Base and Market Access

Established partnerships and ongoing commercial activities supporting biologics and medical aesthetics initiatives across the Middle East region.

🇹🇷 Turkey & Iraq - Regional Operations (R&D & Distribution)

Scientific Base and Market Access

Established partnerships and ongoing commercial activities supporting biologics and medical aesthetics initiatives across the Middle East region.

🇮🇶 Iraq - Regional Operations (R&D & Distribution)

Scientific Base and Market Access

Established partnerships and ongoing commercial activities supporting biologics and medical aesthetics initiatives across the Middle East region.

🇨🇳 China - Strategic Manufacturing & EU Access

Partner Ecosystems for Scalable Supply

Building long-term strategic partnerships for cross-border collaboration, supply pathway optimization, and international market positioning.

🇰🇷 South Korea - Strategic Manufacturing & EU Access

Partner Ecosystems for Scalable Supply

Building long-term strategic partnerships for cross-border collaboration, supply pathway optimization, and international market positioning.

🇪🇸 Spain - Strategic Manufacturing & EU Access

Partner Ecosystems for Scalable Supply

Building long-term strategic partnerships for cross-border collaboration, supply pathway optimization, and international market positioning.

Resources

Insights & Resources

Technical perspectives demonstrating competence in technology transfer and market access.

Technology Transfer Readiness

What to have before onboarding a manufacturing partner.

  • Technical package readiness
  • Documentation structure
  • Partner qualification criteria

CMC Documentation for Multi-Market Submissions

From data room to dossier: structuring CMC documentation for regulatory success.

  • Data room organization
  • Dossier structuring
  • Regional requirements mapping

Cold Chain Planning for Temperature-Sensitive Injectables

Ensuring product stability from manufacture to patient administration.

  • Storage and stability requirements
  • Distribution network design
  • Regulatory alignment

Market Access Basics

Aligning regulatory and commercial launch timelines for maximum impact.

  • Regulatory pathway selection
  • Launch timeline coordination
  • Commercial readiness assessment

Transfer Documentation Best Practices

Preparing transfer-ready technical packages without disclosing confidential data.

  • Documentation standards
  • IP protection strategies
  • Quality system integration

Partner Qualification and Governance

Building sustainable partnerships with defined roles, milestones, and accountability.

  • Qualification frameworks
  • Governance structures
  • Performance monitoring
Contact

Get in Touch

Ready to collaborate? Let's build together.

Let's Build the Next Collaboration

Atlas Group brings execution discipline, cross-border capability, and partner alignment to turn complex opportunities into scalable, compliant, and commercially viable growth in biologics and medical aesthetics.

Contact Us

Contact Atlas Group

Get in touch to discuss opportunities.

Let's Discuss Your Technology Transfer or Market Entry Program

Share your target markets, project type, and current technical package. We will respond within one business day with the next-step options.

Loading
Your message has been sent. Thank you!

Contact Information

Reach out to Atlas for inquiries about technology transfer, market entry, or strategic collaborations in biologics and medical aesthetics.

Email

info@atlaspharma.co

Phone

+98 21 4881 9112

Address

Unit 1, Floor 4, Contrast Building
Allameh Ghazvini St., Rah Ahan Town
Tehran, Iran

Connect with us